Regulated Information
Financial Reports
06
May
2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
05
Aug
2022
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
SEC Filings
Filter
Filing Date | Form | Description | Filing Group | Downloads |
---|---|---|---|---|
August 4, 2021 | 6-K | Celyad Oncology Reports First Half 2021 Financial Results And Recent Business Highlights | ||
July 21, 2021 | 6-K | Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day | ||
June 11, 2021 | 6-K | Celyad Oncology Presents Preliminary Data From Phase 1 IMMUNICY-1 Trial Of ShRNA-Based Allogeneic CAR T Candidate CYAD-211 In r/r MM At The EHA Virtual Congress | ||
May 12, 2021 | 6-K | Report of Foreign Issuer | Current reports | |
May 7, 2021 | 6-K | Report of Foreign Issuer | Current reports | |
March 25, 2021 | 20-F | Annual and Transition Report (foreign private issuer) | Other |